ADEL-102

N/A

Report date: 2024/02/28 16:18:36
NME

Base Information

Drug NameADEL-102
Drug Alias NameADEL-102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsRhabdomyosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptadel Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesAptadel Therapeutics SL
Inactive CompaniesN/A
Active IndicationsRhabdomyosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A